Standard protocol of ALK fusion gene assessment by fluorescent in situ hybridization in non-small cell lung cancer / 中华病理学杂志
Chinese Journal of Pathology
;
(12): 530-533, 2013.
Article
in Chinese
| WPRIM
| ID: wpr-233403
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the standard protocol for anaplastic lymphoma kinase (ALK) fusion gene assessment by fluorescent in situ hybridization (FISH) in non-small cell lung cancer (NSCLC).</p><p><b>METHODS</b>Tissue specimens of NSCLC cases were retrospectively collected from Jan. 2011 to July 2012. ALK fusion gene was examined by FISH using break-apart ALK gene probes (Vysis company). The identification of ALK fusion gene was determined by fluorescent signals under a fluorescence microscope.</p><p><b>RESULTS</b>One hundred and forty-six eligible NSCLC tumor specimens were tested for ALK fusion gene by FISH. The specimens included 110 cases (75.4%) of surgically-removed tissues, 11 cases (7.5%) of biopsy, 19 cases (13.0%) of lymph node and 6 cases (4.1%) of other metastatic tissues. The positivity of ALK fusion gene was 8.9% (13/146).</p><p><b>CONCLUSIONS</b>The assessment of ALK fusing gene by FISH using standard protocol for formalin-fixed, paraffin-embedded (FFPE) tissue is feasible. The protocol can used to test in surgically-removed tissues, biopsies, metastatic lymph nodes and other metastastic specimens.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
General Surgery
/
Oncogene Proteins, Fusion
/
Retrospective Studies
/
Paraffin Embedding
/
In Situ Hybridization, Fluorescence
/
Receptor Protein-Tyrosine Kinases
/
Carcinoma, Non-Small-Cell Lung
/
Gene Fusion
/
Genetics
/
Lung Neoplasms
Type of study:
Observational study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
Chinese
Journal:
Chinese Journal of Pathology
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS